Long Term Inhibition of Interleukin (IL)-17A with Secukinumab Improves Clinical Symptoms and Reduces Spinal Inflammation As Assessed by Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis
Author(s):
Baraliakos, X.; Braun, J.; Laurent, D.D.; Baeten, D.; Heijde, D. van der; Sieper, J.; Emery, P.; McInnes, I.B.; Laar, J. van; Landewe, R.; Wordsworth, P.; Wollenhaupt, J.; Kellner, H.; Wright, A.; Vandenhende, F.; Radford, K.; Borah, B.; Wolfgang, H.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-10-31
Language
English
Is part of
Arthritis and Rheumatism (2012), Vol. 64, no. 10, p. S250-S251
